Cardiometabolic and Lipids
2025 Clinical Practice Guideline for the Pharmacologic Management of Adults with Dyslipidemia
Cardiometabolic and Lipids
Clinical Practice Guidelines
Podcasts
This guideline was developed by a multidisciplinary task force and uses the GRADE framework to provide evidence-based recommendations regarding cardiovascular risk assessment, benefits and harms of newer medications, and treatment goals with a focus on patient-important outcomes.
AACE Clinical Guidance Forum
Cardiometabolic and Lipids
Nutrition and Obesity
Pituitary, Gonad, Adrenal and Neuroendocrine
Algorithms
Clinical Practice Guidelines
Consensus Statements
Register for the AACE Clinical Guidance Forum, December 10–11, 2025, and be the first to explore the newest AACE guidelines and consensus statements—presented by the experts who created them.
AACE Consensus Statement: Algorithm for Management of Adults with Dyslipidemia – 2025 Update
Cardiometabolic and Lipids
Algorithms
Co-sponsored Clinical Guidance
Consensus Statements
Podcasts
This algorithm was developed by a task force of practicing endocrinologists, including international experts, to provide visual guidance for managing adults with dyslipidemia and to aid clinicians in navigating the complexities of screening, diagnostic testing, and treatment.
AvoMD Integrates AACE Clinical Guidance Documents
Bone and Parathyroid
Cardiometabolic and Lipids
Diabetes
Nutrition and Obesity
Pituitary, Gonad, Adrenal and Neuroendocrine
Thyroid
Clinical Practice Guidelines
AvoMD, a software platform that brings clinical evidence into the workflow to help clinicians streamline decisions and save time, has partnered with AACE to integrate clinical guidance documents into the AvoMD platform. This partnership provides endocrinologists, primary care physicians, nurse practitioners, physician assistants/physician associates, and dietitians with seamless access to evidence-based endocrinology recommendations at the point-of-care.
2022 Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
Cardiometabolic and Lipids
Algorithms
Clinical Practice Guidelines
Co-sponsored Clinical Guidance
Podcasts
This guideline provides evidence-based recommendations regarding the diagnosis and management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) to endocrinologists, primary care clinicians, health care professionals, and other stakeholders.
2013 Consensus Statement on the Clinical Approach to the Detection of Lipodystrophy
Cardiometabolic and Lipids
Consensus Statements
Lipodystrophy is a rare, heterogeneous group of syndromes characterized by the complete or partial loss or absence of subcutaneous adipose tissue. This consensus statement provides an overview of the literature and expert opinion on recognizing lipodystrophy and some potential management strategies.
Endorsed Clinical Guidance
Bone and Parathyroid
Cardiometabolic and Lipids
Diabetes
Nutrition and Obesity
Pituitary, Gonad, Adrenal and Neuroendocrine
Thyroid
Co-sponsored Clinical Guidance
Endorsed Clinical Guidance
After careful review, AACE may endorse clinical guidance documents developed by external organizations to provide up-to-date recommendations for practice or valuable ancillary knowledge for AACE members and their teams to improve care of patients. Endorsements are reviewed and approved by AACE leadership.